Qube Research & Technologies LTD Legend Biotech Corp Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$55.06 - $69.99 $10.2 Million - $13 Million	-185,852 Reduced 91.94%	16,284 $913,000
Q4 2023 Feb 13, 2024	BUY	$57.25 - $69.74 $11.4 Million - $13.9 Million	199,839 Added 8700.0%	202,136 $12.2 Million
Q3 2023 Nov 13, 2023	BUY	$63.16 - $76.5 $145,078 - $175,720	2,297 New	2,297 $154,000
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $3.3 Million - $4.72 Million	-85,137 Reduced 79.35%	22,154 $1.11 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $4.09 Million - $6.13 Million	107,291 New	107,291 $4.38 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $1.01 Million - $1.65 Million	-30,032 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$31.02 - $48.18 $931,592 - $1.45 Million	30,032 New	30,032 $1.09 Million
Q3 2020 Nov 12, 2020	SELL	$27.5 - $39.61 $132,907 - $191,435	-4,833 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $174,471 - $205,692	4,833 New	4,833 $206,000

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.